Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,100Open textbooks2Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology107Genetics and Genomics95Neuroscience110Cardiovascular Medicine105Immunology90Pharmacology99Molecular Biology100Infectious Diseases102Rare and Inherited Diseases106Clinical Research98Anatomy and Physiology542Drugs and Chemicals546
Plans & pricingCompare EvidenceHelix workspace plans
Library›EvidenceLib›Immunology›Disease Resistance
Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Research reading room

Disease Resistance

Immunology · NLM MeSH · updated 2026-10-29 · version 1

Citations verified against PubMedNot yet clinician-reviewed9 referencesApproximately 3 min read

The capacity of an organism to defend itself against pathological processes or the agents of those processes.

Table of Contents

1. Definition2. Research landscape3. Reading the evidence4. Open-access studies5. Key reviews6. References7. About this article

Definition and research guide

This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.

Content available: 3 complete abstracts (584 words), 9 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.

Definition

The capacity of an organism to defend itself against pathological processes or the agents of those processes. This most often involves innate immunity whereby the organism responds to pathogens in a generic way. The term disease resistance is used most frequently when referring to plants.

Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.

Also known as: Disease Resistances; Resistances, Disease; Resistance, Disease.

Where it fits in the MeSH classification

Broader topics
Disease Attributes; Immunity, Innate; Plant Immunity

Research landscape

PubMed indexes 15,680 records tagged with the MeSH heading “Disease Resistance” (counts retrieved 2026-10-29). 8,078 of them (51.5%) were published from 2020 onward, and the busiest period so far is 2020 onward with 8,078 records.

Reviews account for 1,343 records (8.6%) and meta-analyses for 38. Randomized controlled trials number 18 (0.1%) as a share of all records on the topic. Randomized trials make up only a small share of this literature, so much of what is known comes from laboratory, observational or descriptive work.

PubMed records by publication periodthrough 1999: 0 records; 2000-2009: 4 records; 2010-2019: 7,759 records; 2020 onward: 8,078 records0through 199942000-20097,7592010-20198,0782020 onward
Records in PubMed indexed with this heading, by publication period. Real counts from NCBI E-utilities; the final period covers only part of the current year. Volume reflects how much has been published, not how strong the evidence is.
Show the data
PeriodRecords
through 19990
2000-20094
2010-20197,759
2020 onward8,078
Share of records by publication typeReviews: 8.6 percent; Meta-analyses: 0.2 percent; Randomized controlled trials: 0.1 percentReviews8.6% (1,343)Meta-analyses0.2% (38)Randomized controlled trials0.1% (18)
Share of all PubMed records on this heading that carry each publication type. Types overlap with other records, so the shares do not sum to 100%.
Publication-type chart data
Publication types among 15,680 PubMed records
TypeRecordsShare
Reviews1,3438.6%
Meta-analyses380.2%
Randomized controlled trials180.1%

Method: PubMed query "Disease Resistance"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-29.

Reading the evidence in immunology

Immune responses are studied in model organisms, in cells from donors and in patients, and the same pathway can behave differently across these settings. Mouse immune systems differ from human ones in important ways, and blood measurements may not reflect what happens in tissues. Clinical conclusions about immune-mediated disease or immunotherapy come mainly from controlled trials and long-term cohorts. Check the species and tissue studied, whether markers were linked to outcomes patients notice, and the follow-up time.

Evidence from open-access studies

These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.

Study comparison — selected abstracts, not a systematic review
Study / authorsYearSource label / designEurope PMC citationsLicence / source
Virulence on Pm4 kinase-based resistance is determined by two divergent wheat powdery mildew effectors
Bernasconi Z, Herger AG, Caro MDP, Kunz L, Müller MC, Stirnemann U, et al.
2026Research article
Design not recorded in structured metadata
8cc by
PMID 41526694 · DOI · PMC12830362
Mechanistic Insights for Microbiome Application in Plant Disease Resistance
Yin J
2026Review article
Design not recorded in structured metadata
5cc by
PMID 41793016 · DOI · PMC12966624
Changes in gene regulation are associated with the evolution of resistance to a novel parasite
Fuess LE, Hund AK, Kenney ML, Maciejewski MF, Marini JM, Bolnick DI
2026Research article
Design not recorded in structured metadata
4cc by
PMID 41836432 · DOI · PMC12979160

Virulence on Pm4 kinase-based resistance is determined by two divergent wheat powdery mildew effectors [1]

Research article Bernasconi Z, Herger AG, Caro MDP, Kunz L, Müller MC, Stirnemann U, et al. · · 2026 · cited 8 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
The wheat resistance gene Pm4 encodes a kinase fusion protein and has gained particular attention as it confers race-specific resistance against two major wheat pathogens: powdery mildew and blast.
Closing excerpt
These multiple roles of a single effector provide a new perspective on fungal (a)virulence proteins and their combinatorial interactions with different types of immune receptors.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (150 words)

The wheat resistance gene Pm4 encodes a kinase fusion protein and has gained particular attention as it confers race-specific resistance against two major wheat pathogens: powdery mildew and blast. Here we describe the identification of AvrPm4, the mildew avirulence effector recognized by Pm4, using UV mutagenesis, and its functional validation in wheat protoplasts. We show that AvrPm4 directly interacts with and is phosphorylated by Pm4. Using genetic association and quantitative trait locus mapping, we further demonstrate that the evasion of Pm4 resistance by virulent mildew isolates relies on a second fungal component, SvrPm4, which suppresses AvrPm4-induced cell death. Surprisingly, SvrPm4 was previously described as AvrPm1a. We show that SvrPm4, but not its inactive variant svrPm4, is recognized by the nucleotide-binding leucine-rich repeat immune receptor Pm1a. These multiple roles of a single effector provide a new perspective on fungal (a)virulence proteins and their combinatorial interactions with different types of immune receptors.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 41526694 · DOI · PMC12830362

Mechanistic Insights for Microbiome Application in Plant Disease Resistance [2]

Review article Yin J · · 2026 · cited 5 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Plant diseases caused by biotic and abiotic stresses pose a great threat to both plant health and yield.
Closing excerpt
I also raise work and challenges that should be addressed, with the ultimate goal of informing more efficient microbiome application in sustainable agriculture.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (170 words)

Plant diseases caused by biotic and abiotic stresses pose a great threat to both plant health and yield. Plant microbiomes play a crucial role in improving disease resistance, representing a sustainable approach to enhance crop performance. Plant host factors, including genetic variation, metabolites and microRNA, shape the assembly and function of the plant microbiome, thereby augmenting disease resistance. This interplay presents opportunities for plant-mediated manipulation of microbiome to promote plant health. Multiple mechanisms are involved in the microbiome-mediated plant disease resistance, such as direct and indirect pathogen antagonism, niche pre-emption, alteration of microbiota and activation of plant defences. Nevertheless, the application of plant microbiome in the field remains limited due to the intrinsic complexity of plant-microbiome and environment-microbiome interactions. This review synthesises current knowledge on the roles of plant microbiomes in plant disease resistance. I further summarise the mechanisms underlying plant-guided microbiome modulation and probiotic-mediated disease suppression. I also raise work and challenges that should be addressed, with the ultimate goal of informing more efficient microbiome application in sustainable agriculture.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 41793016 · DOI · PMC12966624

Changes in gene regulation are associated with the evolution of resistance to a novel parasite [3]

Research article Fuess LE, Hund AK, Kenney ML, Maciejewski MF, Marini JM, Bolnick DI · · 2026 · cited 4 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
IntroductionHost-parasite interactions are ubiquitous and are important drivers of host diversification and evolution.
Closing excerpt
ConclusionOur results provide strong evidence that changes in gene regulation and increased negative feedback to mitigate immunopathology are essential steps in the evolutionary co-option of an existing pathway to defend against a new parasite infection.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (264 words)

IntroductionHost-parasite interactions are ubiquitous and are important drivers of host diversification and evolution. In particular, host immune systems are frequent targets of parasite-driven selection. The resulting rapid evolution of immune genes is usually framed as an ongoing 'arms race' between a co-evolving pair of host and parasite species. However, immune evolution may often be driven by the acquisition of a new and unfamiliar parasite. For instance, when marine populations of threespine stickleback (Gasterosteus aculeatus) colonized freshwater lakes approximately 12,000 years ago, they encountered the freshwater-restricted cestode Schistocephalus solidus and evolved resistance.MethodsWe compared the transcriptomic responses of lab-reared sticklebacks from three populations of stickleback with varying cestode susceptibilities when exposed to several immune stimuli (alum, cestode protein, or a control injection).ResultsThe resulting changes in expression reveal strong evidence of shared and population-specific responses during the evolution of defense against a new parasite. Our investigation highlights the roles of several key immunological processes in underlying a general physiological response to tissue damage (fibrosis) and the importance of regulating fibrosis as a necessary step for its co-option into defense against S. solidus tapeworms. Furthermore, we highlighted changes in the expression of fibrosis-associated genes, which facilitate faster and more targeted deployment of this defense mechanism against parasites. Fish from the most fibrosis-prone population exhibited constitutively higher expression of fibrosis-associated genes and stronger downregulation of these genes after an initial stimulus from injected cestode proteins.ConclusionOur results provide strong evidence that changes in gene regulation and increased negative feedback to mitigate immunopathology are essential steps in the evolutionary co-option of an existing pathway to defend against a new parasite infection.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 41836432 · DOI · PMC12979160

Key reviews and meta-analyses

The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.

  • Research article Plant hormone-mediated regulation of stress responses [4]
    Verma V, Ravindran P, Kumar PP · BMC Plant Biol · 2016 · cited 1,177 times (Europe PMC)
  • Research article The plant immune system: From discovery to deployment [5]
    Jones JDG, Staskawicz BJ, Dangl JL · Cell · 2024 · cited 433 times (Europe PMC)
  • Research article Mechanisms of cancer resistance in long-lived mammals [6]
    Seluanov A, Gladyshev VN, Vijg J, Gorbunova V · Nat Rev Cancer · 2018 · cited 249 times (Europe PMC)
  • Research article Microbiota-mediated disease resistance in plants [7]
    Vannier N, Agler M, Hacquard S · PLoS Pathog · 2019 · cited 203 times (Europe PMC)
  • Research article The role of host genetics in the immune response to SARS-CoV-2 and COVID-19 susceptibility and severity [8]
    Ovsyannikova IG, Haralambieva IH, Crooke SN, Poland GA, Kennedy RB · Immunol Rev · 2020 · cited 182 times (Europe PMC)
  • Research article The role of volatiles in plant communication [9]
    Bouwmeester H, Schuurink RC, Bleeker PM, Schiestl F · Plant J · 2019 · cited 181 times (Europe PMC)

References

  1. Bernasconi Z, Herger AG, Caro MDP, Kunz L, Müller MC, Stirnemann U, et al.. Virulence on Pm4 kinase-based resistance is determined by two divergent wheat powdery mildew effectors. . 2026. PMID 41526694 · DOI · PMC12830362
  2. Yin J. Mechanistic Insights for Microbiome Application in Plant Disease Resistance. . 2026. PMID 41793016 · DOI · PMC12966624
  3. Fuess LE, Hund AK, Kenney ML, Maciejewski MF, Marini JM, Bolnick DI. Changes in gene regulation are associated with the evolution of resistance to a novel parasite. . 2026. PMID 41836432 · DOI · PMC12979160
  4. Verma V, Ravindran P, Kumar PP. Plant hormone-mediated regulation of stress responses. BMC Plant Biol. 2016. PMID 27079791 · DOI · PMC4831116
  5. Jones JDG, Staskawicz BJ, Dangl JL. The plant immune system: From discovery to deployment. Cell. 2024. PMID 38670067 · DOI
  6. Seluanov A, Gladyshev VN, Vijg J, Gorbunova V. Mechanisms of cancer resistance in long-lived mammals. Nat Rev Cancer. 2018. PMID 29622806 · DOI · PMC6015544
  7. Vannier N, Agler M, Hacquard S. Microbiota-mediated disease resistance in plants. PLoS Pathog. 2019. PMID 31194849 · DOI · PMC6564022
  8. Ovsyannikova IG, Haralambieva IH, Crooke SN, Poland GA, Kennedy RB. The role of host genetics in the immune response to SARS-CoV-2 and COVID-19 susceptibility and severity. Immunol Rev. 2020. PMID 32658335 · DOI · PMC7404857
  9. Bouwmeester H, Schuurink RC, Bleeker PM, Schiestl F. The role of volatiles in plant communication. Plant J. 2019. PMID 31410886 · DOI · PMC6899487

About this article

Sources
NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
Verification
Every reference was resolved against PubMed on 2026-10-31; title, year and DOI matched.
Review state
automated source verified; no human expert review has been recorded yet.
Version
1, last updated 2026-10-29.

See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.

Evidence strength

EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.

Included with the Researcher plan

Reading every article stays free. This computed view is part of the paid plans.

See plans Sign in

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.

Related research topics

  • Airway ResistanceAnatomy and Physiology
  • Chronic UrticariaImmunology
  • PhagocytosisImmunology
  • Plant ImmunityImmunology
  • Trained ImmunityImmunology
  • Blast CrisisCancer and Oncology

All 90 articles in Immunology →

At a glance

15,680
PubMed records on this heading
52%
published since 2020
1,343
review articles
18
randomized trials
9
verified references below

Counts come from PubMed on 2026-10-29; they show how much has been written, not how strong the evidence is.

Related topics See all →

  • Airway ResistanceAnatomy and Physiology
  • Chronic UrticariaImmunology
  • PhagocytosisImmunology
  • Plant ImmunityImmunology
  • Trained ImmunityImmunology

My notes & annotations (0)

Nothing yet. Select text and press Highlight, or write a note in the Notes tab. Stored in this browser only.

Sources

  • NLM MeSH record ↗
  • PubMed search used ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Legal · Support